Skip to main content
SpringerLink
Log in

Clinical Pharmacology of Vitamin A and Retinoids

  • Chapter
Clinical and Biological Basis of Lung Cancer Prevention

Part of the book series: Respiratory Pharmacology and Pharmacotherapy ((RPP))

  • 91 Accesses

Abstract

Natural vitamin A (all-trans retinol, retinal, and retinyl esters; Figure 1) is essential for vision, reproduction and maintenance of differentiated epithelia and mucus secretion in humans and higher animals [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Goodman DS (1984) Vitamin A and retinoids in health and disease. N Engl J Med 310: 1023–1031.

    Article  CAS  PubMed  Google Scholar 

  2. Dowling JE, Wald J (1960) The biological function of vitamin A acid. Proc Natl Acad Sci USA 46: 587–608.

    Article  CAS  PubMed  Google Scholar 

  3. Thompson JN, Howell JM, Pitt GAJ (1964) Vitamin A and reproduction in rats. Proc R Soc Lond 159: 510–535.

    Article  CAS  PubMed  Google Scholar 

  4. Blomhoff R, Green MH, Green JB, Berg T, Norum KR (1991) Vitamin A metabolism: new perspectives on absorption, transport and storage. Physiol Rev 71: 951–990.

    CAS  PubMed  Google Scholar 

  5. Wald NJ, Cuckle HS, Barlow RD, Thompson P, Nanchahal K, Blow RJ, Brown I, Harling CC, McCulloch WJ, Morgan J, Reid AR (1985) The effect of vitamin A supplementation on serum retinol and retinol-binding protein levels. Cancer Letters 29: 203–213.

    Article  CAS  PubMed  Google Scholar 

  6. Goodman GE, Alberts DS, Peng YM, Beaudry J, Leigh SA, Moon T (1984) Plasma kinetics of oral retinol in cancer patients. Cancer Treat Rep 68: 1125–1133.

    CAS  PubMed  Google Scholar 

  7. Plezia PM, Alberts DS, Peng YM, Xu MJ, Sayers S, Davis BT, Surwit EA, Meyskens F (1989) The role of serum and tissue pharmacology studies in the design and interpretation of chemoprevention trials. Preventive Medicine 18: 680–687.

    Article  CAS  PubMed  Google Scholar 

  8. Infante M, Pastorino U, Chiesa G, Bera E, Pisani P, Valente M, Ravasi G (1991) Laboratory evaluation during high-dose vitamin A administration: a randomised study on lung cancer patients after surgical resection. J Cancer Res Clin Oncol 117: 156–162.

    Article  CAS  PubMed  Google Scholar 

  9. Korner WF, Vollm J (1975) New aspects of the tolerance of retinol in humans. Int J Vit Nutr Res 45: 363–372.

    CAS  Google Scholar 

  10. Fidge NH, Shiratori T, Ganguly J, Goodman DS (1968) Pathways of absorption of retinal and retinoic acid in the rat. J Lipid Res 9: 103–109.

    CAS  PubMed  Google Scholar 

  11. Wathne KO, Norum KR, Smeland E, Blomhoff R (1988) Retinol bound to physiological carrier molecules regulates growth and differentiation of myeloid leukemic cells. J Biol Chem 263: 8691–8695.

    CAS  PubMed  Google Scholar 

  12. Pastorino U, Chiesa G, Infante M, et al. (1991) Safety of high-dose vitamin A. Randomized trial on lung cancer chemoprevention. Oncology 48: 131–137.

    Article  CAS  PubMed  Google Scholar 

  13. Warrell RP Jr (1993) Acquired retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications. Blood 82: 1949–1953.

    CAS  PubMed  Google Scholar 

  14. Huang ME, Ye YC, Chen JR, et al. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567–572.

    CAS  PubMed  Google Scholar 

  15. Fenaux P, Le Dely MC, Castaigne S, Archimbaud E, Chomienne C, Link H, et al. (1993) Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia: results of a multicenter randomized trial. Blood 82: 3241–3249.

    CAS  PubMed  Google Scholar 

  16. Lefebvre P, Thomas G, Gourmel B, Agadir A, Castaigne S, Dreux C, et al. (1991) Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Leukemia 5: 1054–1058.

    CAS  PubMed  Google Scholar 

  17. Muindi J, Frankel S, Huselton C, DeGrazia F, Garland W, Young CW, et al. (1992) Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 52: 2138–2142.

    CAS  PubMed  Google Scholar 

  18. Brazzell RK, Vane FM, Ehmann CW, Colburn WA (1983) Pharmacokinetics of isotretinoin during repetitive dosing to patients. Eur J Clin Pharmacol 24: 695–702.

    Article  CAS  PubMed  Google Scholar 

  19. Formelli F, Clerici M, Campa T, Di Mauro MG, Magni A, Mascotti G, Moglia D, De Palo G, Costa A, Veronesi U (1993) Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J Clin Oncol 11: 2036–2042.

    CAS  PubMed  Google Scholar 

  20. Wiegand UW, Busslinger AA, Chou RC, Jensen BK (1993) The pharmacokinetics of acitretin in humans: an update. In: Livrea MA, Packer L (eds): Retinoids. Progress in research and clinical application, M. Dekker, Inc., New York, pp 617–628.

    Google Scholar 

  21. Massarella JW, Vane FM (1985) Etretinate kinetics during chronic dosing in severe psoriasis. Clin Pharmacol Ther 37: 439–446.

    Article  CAS  PubMed  Google Scholar 

  22. Muindi J, Frankel SR, Miller WH Jr, Jakubowski A, Scheinberg DA, Young CW, et al. (1992) Continuous treatment with all-trans retinoic acid results in a progressive decrease in plasma concentrations: implications for relapse and retinoid “resistance” in acute promyelocytic leukemia. Blood 79: 299–303.

    CAS  PubMed  Google Scholar 

  23. Rigas JR, Francis PA, Muindi JRF, Huselton C, DeGrazia F, Kris MG, Young CW, Warrell RP Jr (1993) Constitutive variability in catabolism of the natural retinoid, all-trans retinoic acid, and its modulation by ketoconazole. J Natl Cancer Inst 85: 1921–1926.

    Article  CAS  PubMed  Google Scholar 

  24. Miller VA, Rigas JR, Muindi JRF, Tong WP, Venkatraman E, Kris MG, Warrell RP (1994) Modulation of all-trans retinoic acid pharmacokinetics by liarazole. Cancer Chemother Pharmacol 34: 522–526.

    Article  CAS  PubMed  Google Scholar 

  25. Warrell RP Jr, de The H, Wang Z-Y, Degos L (1993) Acute promyelocytic leukemia. N Engl J Med 329: 177–189.

    Article  CAS  PubMed  Google Scholar 

  26. Hong WK, Endicott J, Itri L, et al. (1986) 13-cis-retinoic acid in the treatment of oral leukoplakia. New Engl J Med 315: 1501–1505.

    Article  CAS  PubMed  Google Scholar 

  27. Hong WK, Lippman JM, Itri L, et al. (1990) Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 323: 795–801.

    Article  CAS  PubMed  Google Scholar 

  28. Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, Hays GL, Goepfert H, Hong WK (1993) Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 328: 15–20.

    Article  CAS  PubMed  Google Scholar 

  29. Kerr IG, Lippman ME, Jenkins J, Myers C (1982) Pharmacology of 13-cis-retinoic acid in humans. Cancer Res 42: 2069–2073.

    CAS  PubMed  Google Scholar 

  30. Goodman GE, Alberts DS, Peng YM, Beaudry J, Einspahr J, Leigh S, Miles NJ, Davis TP, Meyskens FL (1983) Pharmacokinetics and phase I trial of retinol and 13-cis-retinoic acid. In: Modulation and mediation of cancer by vitamins, pp 311–316, Karger, Basel.

    Google Scholar 

  31. Khoo KC, Reik FD, Colburn WA (1982) Pharmacokinetic profile of isotretinoin following a single oral dose to normal man. J Clin Pharmacol 22: 395–402.

    Article  CAS  PubMed  Google Scholar 

  32. Berni R, Clerici M, Malpeli G, Cleris L, Formelli F (1993) Retinoids: in vitro interaction with retinol-binding protein and influence on plasma retinol. FASEB J 7: 1179–1184.

    CAS  PubMed  Google Scholar 

  33. Desiraju RK, Scott V, Nayak RK, Minn FL (1985) Pharmacokinetics of fenretinide in healthy volunteers. Clin Pharmacol Ther 37(2): 190.

    Google Scholar 

  34. Peng YM, Dalton WS, Alberts DS, Xu MJ, Lim H, Meyskens FL (1989) Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients. Int J Cancer 43: 22–26, 1989. Erratum: Int J Cancer 44: 567.

    Article  CAS  PubMed  Google Scholar 

  35. Doose DR, Minn FL, Stellar S, Nayak RK (1992) Effects of meals and meal composition on the bioavailability of fenretinide. J Clin Pharmacol 32: 1089–1095.

    CAS  PubMed  Google Scholar 

  36. Formelli F, Carsana R, Costa A, Buranelli F, Campa T, Dossena G, Magni A Pizzichetta M. (1989) Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients. Cancer Res 49: 6149–6152.

    CAS  PubMed  Google Scholar 

  37. Dimitrov NV, Meyer CJ, Perloff M, Ruppenthal MM, Phillipich MJ, Gilliland D, Malone W, Minn FL (1990) Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects. Am J Clin Nutr 51: 1082–1087.

    CAS  PubMed  Google Scholar 

  38. Kaiser-Kupfer MI, Peck GL, Caruso RC (1986) Abnormal retinal function associated with fenretinide, a synthetic retinoid. Arch Ophtalmol 104: 69–70.

    Article  CAS  Google Scholar 

  39. Costa A, Malone W, Perloff M, Buranelli F, Campa T, Dossena G, Magni A, Pizzichetta M, Andreoli C, Del Vecchio M, Formelli F, Barbieri A (1989) Tolerability of the synthetic retinoid fenretinide (HPR). Eur J Cancer Clin Oncol 25: 805–808.

    Article  CAS  PubMed  Google Scholar 

  40. Decensi A, Torrisi R, Polizzi A, Gesi R, Brezzo V, Rolando M, Rondanina G, Orengo MA, Formelli F, Costa A (1994) Effect of the synthetic retinoid fenretinide on dark adaptation and the ocular surface. J Natl Cancer Inst 86: 105–110.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery Royal Brompton Hospital, London, UK

    Ugo Pastorino

  2. Istituto Nazionale Tumori, Milan, Italy

    Franca Formelli

Authors
  1. Ugo Pastorino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Franca Formelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hôpital de Brabois Service de Pneumologie A, Centre Hospitalier Universitaire de Nancy, 54511, Vandoeuvre-lès-Nancy, France

    Yves Martinet

  2. The Finsen Center Department of Oncology 5074, Copenhagen University Hospital Rigshospitalet, DK-2100, Copenhagen, Denmark

    Fred R. Hirsch

  3. Unité de Recherche de Physipathologie Respiratoire, INSERM U14, C.O. No 10, 54511, Vandoeuvre-lès-Nancy, France

    Nadine Martinet

  4. Service d’Anatomie Pathologique, Centre Hospitalier Universitaire de Nancy Hôpital Central, 54035, Nancy, France

    Jean-Michel Vignaud

  5. National Cancer Institute / National Institutes of Health, Division of Clinical Sciences / Medicine Branch Cell and Cancer Biology Department, Rockville, MD, 20850-3300, USA

    James L. Mulshine

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Basel AG

About this chapter

Cite this chapter

Pastorino, U., Formelli, F. (1998). Clinical Pharmacology of Vitamin A and Retinoids. In: Martinet, Y., Hirsch, F.R., Martinet, N., Vignaud, JM., Mulshine, J.L. (eds) Clinical and Biological Basis of Lung Cancer Prevention. Respiratory Pharmacology and Pharmacotherapy. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8924-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8924-7_3

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9829-4

  • Online ISBN: 978-3-0348-8924-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation